| ［1］ |
|
| ［2］ |
|
| ［3］ |
|
| ［4］ |
Liu D， Huang SY， Sun JH， et al. Sepsis-induced immunosuppression： mechanisms， diagnosis and current treatment options［J］. Mil Med Res， 2022， 9： 56. DOI： 10.1186/s40779-022-00422-y.
|
| ［5］ |
|
| ［6］ |
Wang Z， Wang Z. The role of macrophages polarization in sepsis-induced acute lung injury［J］. Front Immunol， 2023， 14： 1209438. DOI： 10.3389/fimmu.2023.1209438.
|
| ［7］ |
Peace CG， O'Neill LAJ. The role of itaconate in host defense and inflammation［J］. J Clin Invest， 2022， 132（2）： e148548. DOI： 10.1172/JCI148548.
|
| ［8］ |
Luo L， Zhuang X， Fu L， et al. The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury/acute respiratory distress syndrome［J］. Clin Transl Med， 2024， 14（12）： e70098. DOI： 10.1002/ctm2.70098.
|
| ［9］ |
Chousterman BG， Swirski FK， Weber GF. Cytokine storm and sepsis disease pathogenesis［J］. Semin Immunopathol， 2017， 39（5）： 517-528. DOI： 10.1007/s00281-017-0639-8.
|
| ［10］ |
|
| ［11］ |
Weichhart T， Hengstschläger M， Linke M. Regulation of innate immune cell function by mTOR［J］. Nat Rev Immunol， 2015， 15（10）： 599-614. DOI： 10.1038/nri3901.
|
| ［12］ |
|
| ［13］ |
|
| ［14］ |
|
| ［15］ |
|
| ［16］ |
|
| ［17］ |
|
| ［18］ |
|
| ［19］ |
|
| ［20］ |
Feng X， Guan W， Zhao Y， et al. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway［J］. J Cell Physiol， 2019， 234（10）： 18994-19009. DOI： 10.1002/jcp.28539.
|
| ［21］ |
|
| ［22］ |
Li J， Zhai X， Sun X， et al. Metabolic reprogramming of pulmonary fibrosis［J］. Front Pharmacol， 2022， 13： 1031890. DOI： 10.3389/fphar.2022.1031890.
|
| ［23］ |
Cheng S， Li Y， Sun X， et al. The impact of glucose metabolism on inflammatory processes in sepsis-induced acute lung injury［J］. Front Immunol， 2024， 15： 1508985. DOI： 10.3389/fimmu.2024.1508985.
|
| ［24］ |
El Kasmi KC， Stenmark KR. Contribution of metabolic reprogramming to macrophage plasticity and function［J］. Semin Immunol， 2015， 27（4）： 267-275. DOI： 10.1016/j.smim.2015.09.001.
|
| ［25］ |
Michaeloudes C， Bhavsar PK， Mumby S， et al. Role of metabolic reprogramming in pulmonary innate immunity and its impact on lung diseases［J］. J Innate Immun， 2020， 12（1）： 31-46. DOI： 10.1159/000504344.
|
| ［26］ |
|
| ［27］ |
|
| ［28］ |
Ma J， Wei K， Liu J， et al. Glycogen metabolism regulates macrophage-mediated acute inflammatory responses［J］. Nat Commun， 2020， 11： 1769. DOI： 10.1038/s41467-020-15636-8.
|
| ［29］ |
|
| ［30］ |
Bueno M， Calyeca J， Rojas M， et al. Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis［J］. Redox Biol， 2020， 33： 101509. DOI： 10.1016/j.redox.2020.101509.
|
| ［31］ |
Wculek SK， Heras-Murillo I， Mastrangelo A， et al. Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis［J］. Immunity， 2023， 56（3）： 516-530.e9. DOI： 10.1016/j.immuni.2023.01.011.
|
| ［32］ |
Das UN. Serum adipocyte fatty acid-binding protein in the critically ill［J］. Crit Care， 2013， 17（2）： 121. DOI： 10.1186/cc12517.
|
| ［33］ |
Piccioni A， Spagnuolo F， Candelli M， et al. The gut microbiome in sepsis： from dysbiosis to personalized therapy［J］. J Clin Med， 2024， 13（20）： 6082. DOI： 10.3390/jcm13206082.
|
| ［34］ |
Li R， Li X， Zhao J， et al. Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation［J］. Theranostics， 2022， 12（2）： 976-998. DOI： 10.7150/thno.63751.
|
| ［35］ |
Gao XL， Li JQ， Dong YT， et al. Upregulation of microRNA-335-5p reduces inflammatory responses by inhibiting FASN through the activation of AMPK/ULK1 signaling pathway in a septic mouse model［J］. Cytokine， 2018， 110： 466-478. DOI： 10.1016/j.cyto.2018.05.016.
|
| ［36］ |
Kim YC， Lee SE， Kim SK， et al. Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation［J］. Nat Chem Biol， 2019， 15（9）： 907-916. DOI： 10.1038/s41589-019-0344-0.
|
| ［37］ |
Dalli J， Colas RA， Quintana C， et al. Human sepsis eicosanoid and pro-resolving lipid mediator temporal profiles： correlations with survival and clinical outcomes［J］. Crit Care Med， 2017， 45（1）： 58-68. DOI： 10.1097/CCM.0000000000002014.
|
| ［38］ |
Monteiro APT， Soledade E， Pinheiro CS， et al. Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis［J］. Am J Respir Cell Mol Biol， 2014， 50（1）： 87-95. DOI： 10.1165/rcmb.2012-0525OC.
|
| ［39］ |
Spiller F， Oliveira Formiga R， Fernandes da Silva Coimbra J， et al. Targeting nitric oxide as a key modulator of sepsis， arthritis and pain［J］. Nitric Oxide， 2019， 89： 32-40. DOI： 10.1016/j.niox.2019.04.011.
|
| ［40］ |
Zhang JX， Xu WH， Xing XH， et al. ARG1 as a promising biomarker for sepsis diagnosis and prognosis： evidence from WGCNA and PPI network［J］. Hereditas， 2022， 159： 27. DOI： 10.1186/s41065-022-00240-1.
|
| ［41］ |
Zhu Y， Chen X， Lu Y， et al. Glutamine mitigates murine burn sepsis by supporting macrophage M2 polarization through repressing the SIRT5-mediated desuccinylation of pyruvate dehydrogenase［J］. Burns Trauma， 2022， 10： tkac041. DOI： 10.1093/burnst/tkac041.
|
| ［42］ |
Xie T， Lv T， Zhang T， et al. Interleukin-6 promotes skeletal muscle catabolism by activating tryptophan–indoleamine 2，3-dioxygenase 1–kynurenine pathway during intra-abdominal sepsis［J］. J Cachexia Sarcopenia Muscle， 2023， 14（2）： 1046-1059. DOI： 10.1002/jcsm.13193.
|
| ［43］ |
Liu T， Wen Z， Shao L， et al. ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis［J］. Clin Immunol， 2023， 254： 109698. DOI： 10.1016/j.clim.2023.109698.
|
| ［44］ |
Tan C， Gu J， Li T， et al. Inhibition of aerobic glycolysis alleviates sepsis-induced acute kidney injury by promoting lactate/sirtuin 3/AMPK-regulated autophagy［J］. Int J Mol Med， 2021， 47（3）： 19. DOI： 10.3892/ijmm.2021.4852.
|
| ［45］ |
Steiner JL， Crowell KT， Kimball SR， et al. Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle［J］. Am J Physiol Endocrinol Metab， 2015， 309（12）： E981-E994. DOI： 10.1152/ajpendo.00264.2015.
|
| ［46］ |
Gandhirajan A， Roychowdhury S， Vachharajani V. Sirtuins and sepsis： cross talk between redox and epigenetic pathways［J］. Antioxidants， 2021， 11（1）： 3. DOI： 10.3390/antiox11010003.
|
| ［47］ |
Crossland H， Constantin-Teodosiu D， Greenhaff PL. The regulatory roles of PPARs in skeletal muscle fuel metabolism and inflammation： impact of PPAR agonism on muscle in chronic disease， contraction and sepsis［J］. Int J Mol Sci， 2021， 22（18）： 9775. DOI： 10.3390/ijms22189775.
|
| ［48］ |
|
| ［49］ |
|
| ［50］ |
|
| ［51］ |
Horton RA， Knowles RG， Titheradge MA. Endotoxin causes reciprocal changes in hepatic nitric oxide synthesis， gluconeogenesis， and flux through phosphoenolpyruvate carboxykinase［J］. Biochem Biophys Res Commun， 1994， 204（2）： 659-665. DOI： 10.1006/bbrc.1994.2510.
|
| ［52］ |
|
| ［53］ |
|
| ［54］ |
Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury［J］. Front Immunol， 2020， 11： 1722. DOI： 10.3389/fimmu.2020.01722.
|
| ［55］ |
Gong D， Liu X， Wu P， et al. Rab26 alleviates sepsis-induced immunosuppression as a master regulator of macrophage ferroptosis and polarization shift［J］. Free Radic Biol Med， 2024， 212： 271-283. DOI： 10.1016/j.freeradbiomed.2023.12.046.
|
| ［56］ |
Chen F， Wang N， Liao J， et al. Esculetin rebalances M1/M2 macrophage polarization to treat sepsis-induced acute lung injury through regulating metabolic reprogramming［J］. J Cell Mol Med， 2024， 28（21）： e70178. DOI： 10.1111/jcmm.70178.
|
| ［57］ |
Lu S， Li R， Deng Y， et al. GDF15 ameliorates sepsis-induced lung injury via AMPK-mediated inhibition of glycolysis in alveolar macrophage［J］. Respir Res， 2024， 25（1）： 201. DOI： 10.1186/s12931-024-02824-z.
|
| ［58］ |
Mainali R， Zabalawi M， Long D， et al. Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction［J］. eLife， 2021， 10： e64611. DOI： 10.7554/eLife.64611.
|
| ［59］ |
Pant BD， Ahuja A， Roychowdhury S， et al. Mitoquinol improves phagocytosis and glycolysis in ethanol-exposed macrophages via HIF-1α-PFKP axis［J］. J Immunol， 2025： vkaf078. DOI： 10.1093/jimmun/vkaf078.
|
| ［60］ |
Rademann P， Weidinger A， Drechsler S， et al. Mitochondria-targeted antioxidants SkQ1 and MitoTEMPO failed to exert a long-term beneficial effect in murine polymicrobial sepsis［J］. Oxid Med Cell Longev， 2017， 2017： 6412682. DOI： 10.1155/2017/6412682.
|
| ［61］ |
Dong T， Chen X， Xu H， et al. Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases［J］. Pharmacol Ther， 2022， 239： 108208. DOI： 10.1016/j.pharmthera.2022.108208.
|
| ［62］ |
Gao Y， Liu J， Li K， et al. Metformin alleviates sepsis-associated myocardial injury by enhancing AMP-activated protein kinase/mammalian target of rapamycin signaling pathway-mediated autophagy［J］. J Cardiovasc Pharmacol， 2023， 82（4）： 308-317. DOI： 10.1097/FJC.0000000000001463.
|
| ［63］ |
Jin K， Ma Y， Manrique-Caballero CL， et al. Activation of AMP-activated protein kinase during sepsis/inflammation improves survival by preserving cellular metabolic fitness［J］. FASEB J， 2020， 34（5）： 7036-7057. DOI： 10.1096/fj.201901900R.
|
| ［64］ |
Liu W， Guo J， Mu J， et al. Rapamycin protects sepsis-induced cognitive impairment in mouse hippocampus by enhancing autophagy［J］. Cell Mol Neurobiol， 2017， 37（7）： 1195-1205. DOI： 10.1007/s10571-016-0449-x.
|
| ［65］ |
Cheng SC， Quintin J， Cramer RA， et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity［J］. Science， 2014， 345（6204）： 1250684. DOI： 10.1126/science.1250684.
|
| ［66］ |
Li J， Zeng X， Yang F， et al. Resveratrol： potential application in sepsis［J］. Front Pharmacol， 2022， 13： 821358. DOI： 10.3389/fphar.2022.821358.
|
| ［67］ |
Poor TA， Morales-Nebreda L. Alveolar macrophages during inflammation： a balancing act［J］. Am J Respir Cell Mol Biol， 2023， 68（6）： 608. DOI： 10.1165/rcmb.2023-0098ED.
|
| ［68］ |
|
| ［69］ |
Deng Z， Kalin GT， Shi D， et al. Nanoparticle delivery systems with cell-specific targeting for pulmonary diseases［J］. Am J Respir Cell Mol Biol， 2021， 64（3）： 292-307. DOI： 10.1165/rcmb.2020-0306TR.
|